레어노트 - 암·희귀질환 정보
ASO Keyword Dashboard
Tracking 160 keywords for 레어노트 - 암·희귀질환 정보 in Google Play
레어노트 - 암·희귀질환 정보 tracks 160 keywords (no keywords rank yet; 160 need traction). Key metrics: opportunity 70.8, difficulty 44.2.
The fastest way to get information on cancer and rare diseases worldwide
Tracked keywords
160
0 ranked • 160 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
70.8
Top keyword: patients
Avg difficulty
44.2
Lower scores indicate easier wins
Opportunity leaders
- 63.4
patients
Opportunity: 74.0 • Difficulty: 38.9 • Rank —
Competitors: 194
- 64.8
gather
Opportunity: 74.0 • Difficulty: 43.5 • Rank —
Competitors: 967
- 66.1
assistance
Opportunity: 74.0 • Difficulty: 43.9 • Rank —
Competitors: 555
- 64.8
patient
Opportunity: 74.0 • Difficulty: 39.4 • Rank —
Competitors: 203
- 64.6
trial
Opportunity: 74.0 • Difficulty: 44.4 • Rank —
Competitors: 815
Unranked opportunities
patients
Opportunity: 74.0 • Difficulty: 38.9 • Competitors: 194
gather
Opportunity: 74.0 • Difficulty: 43.5 • Competitors: 967
assistance
Opportunity: 74.0 • Difficulty: 43.9 • Competitors: 555
patient
Opportunity: 74.0 • Difficulty: 39.4 • Competitors: 203
trial
Opportunity: 74.0 • Difficulty: 44.4 • Competitors: 815
High competition keywords
time
Total apps: 382,929 • Major competitors: 17,710
Latest rank: — • Difficulty: 57.6
new
Total apps: 367,454 • Major competitors: 23,526
Latest rank: — • Difficulty: 58.6
find
Total apps: 309,306 • Major competitors: 17,804
Latest rank: — • Difficulty: 58.3
information
Total apps: 268,937 • Major competitors: 8,236
Latest rank: — • Difficulty: 54.8
simple
Total apps: 259,866 • Major competitors: 12,379
Latest rank: — • Difficulty: 54.9
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| new | 65 | 100 | 59 | 89 367,454 competing apps Median installs: 3,179 Avg rating: 4.0 | — | — | 23,526 major competitor apps |
| health | 69 | 100 | 49 | 77 70,057 competing apps Median installs: 785 Avg rating: 4.0 | — | — | 1,983 major competitor apps |
| 69 | 100 | 50 | 77 69,714 competing apps Median installs: 2,557 Avg rating: 4.0 | — | — | 3,089 major competitor apps | |
| notifications | 68 | 100 | 54 | 80 99,787 competing apps Median installs: 851 Avg rating: 4.0 | — | — | 3,135 major competitor apps |
| share | 66 | 100 | 58 | 85 218,177 competing apps Median installs: 2,936 Avg rating: 4.1 | — | — | 11,992 major competitor apps |
| right | 67 | 100 | 57 | 83 160,536 competing apps Median installs: 1,956 Avg rating: 4.0 | — | — | 8,880 major competitor apps |
| care | 70 | 100 | 49 | 76 56,412 competing apps Median installs: 1,428 Avg rating: 4.0 | — | — | 2,762 major competitor apps |
| support | 67 | 100 | 55 | 83 172,647 competing apps Median installs: 1,493 Avg rating: 4.1 | — | — | 8,042 major competitor apps |
| tailored | 70 | 100 | 47 | 75 48,918 competing apps Median installs: 638 Avg rating: 4.0 | — | — | 1,729 major competitor apps |
| medical | 71 | 100 | 44 | 72 34,151 competing apps Median installs: 1,261 Avg rating: 3.9 | — | — | 918 major competitor apps |
| medication | 73 | 100 | 36 | 59 5,126 competing apps Median installs: 877 Avg rating: 3.9 | — | — | 112 major competitor apps |
| information | 65 | 100 | 55 | 86 268,937 competing apps Median installs: 1,211 Avg rating: 4.0 | — | — | 8,236 major competitor apps |
| team | 69 | 100 | 52 | 79 86,194 competing apps Median installs: 1,478 Avg rating: 4.0 | — | — | 4,244 major competitor apps |
| management | 68 | 100 | 50 | 80 111,951 competing apps Median installs: 584 Avg rating: 3.9 | — | — | 2,646 major competitor apps |
| control | 67 | 100 | 54 | 82 137,320 competing apps Median installs: 1,856 Avg rating: 3.8 | — | — | 7,574 major competitor apps |
| manage | 66 | 100 | 55 | 84 188,002 competing apps Median installs: 772 Avg rating: 3.9 | — | — | 7,360 major competitor apps |
| way | 66 | 100 | 56 | 85 207,609 competing apps Median installs: 1,996 Avg rating: 4.0 | — | — | 11,517 major competitor apps |
| using | 66 | 100 | 57 | 85 221,047 competing apps Median installs: 2,913 Avg rating: 3.9 | — | — | 12,071 major competitor apps |
| find | 65 | 100 | 58 | 87 309,306 competing apps Median installs: 2,806 Avg rating: 4.1 | — | — | 17,804 major competitor apps |
| time | 64 | 100 | 58 | 89 382,929 competing apps Median installs: 1,508 Avg rating: 4.0 | — | — | 17,710 major competitor apps |
| international | 71 | 100 | 47 | 73 37,054 competing apps Median installs: 2,065 Avg rating: 4.0 | — | — | 2,004 major competitor apps |
| provide | 67 | 100 | 52 | 82 136,413 competing apps Median installs: 1,655 Avg rating: 4.0 | — | — | 4,947 major competitor apps |
| goal | 70 | 100 | 47 | 74 43,559 competing apps Median installs: 1,298 Avg rating: 4.1 | — | — | 1,937 major competitor apps |
| program | 70 | 100 | 46 | 74 43,467 competing apps Median installs: 1,843 Avg rating: 4.1 | — | — | 1,330 major competitor apps |
| basic | 71 | 100 | 49 | 73 38,694 competing apps Median installs: 3,468 Avg rating: 4.0 | — | — | 1,905 major competitor apps |
App Description
The fastest way to get information on cancer and rare diseases worldwide
1. Cancer and Rare Disease Information
- Global News: Receive real-time news from major domestic and international media outlets on cancer and rare diseases. International articles are provided in Korean for easier reading.
- Clinical Trial Status: Real-time updates on domestic and international cancer and rare disease clinical trials allow you to check clinical trial information and the progress of new drug development. AI-assisted summaries provide easy-to-understand guidance on difficult-to-understand clinical trial information. (Source: International - ClinicalTrials.gov, Domestic - Drug Safety Korea)
- Disease Information: Provides essential information for those newly diagnosed with cancer or rare diseases. We gather basic knowledge from trusted organizations such as the Korea Disease Control and Prevention Agency Helpline, StatPearls, and MedlinePlus.
- Patient Group Information: Check out and join patient groups with similar conditions. You can also contribute to raising awareness of rare diseases and cancer by participating in health surveys conducted jointly by Rarenote and patient groups. - News: Receive the latest information on disease-related events, campaigns, seminars, and more. Share this news on Rarenote to reach more patients.
1. Community
- Ask questions about symptoms, prescriptions, medications, and more from patients with the same condition or their guardians.
- Receive real-time notifications of new posts from patients with the same condition and their guardians, allowing you to quickly share information and experiences.
1. Medication Assistance Program
- This program provides partial reimbursement of medication costs for patients with specific conditions who have been recommended by their primary care physician, with support from the sponsor. Those who meet the eligibility criteria are eligible to apply.
- Easily apply for and receive reimbursement through the Rarenote app.
1. Medication Management Program
- This program supports patients using the sponsor's medications to manage their medication more systematically.
- Medication reminders, deferrals, and medication completion records allow you to administer or take medication according to a set schedule, effectively managing your condition and pain.
1. Recommended welfare programs tailored to your needs
- If you need financial or living support to use the sponsor's medication, you can find the right welfare program for you by entering simple information such as income, assets, and residential area.
● Why does Rarenote do this?
Rarenote works to solve various problems faced by cancer and rare disease patients. Ultimately, our goal is to expand treatment opportunities for these patients.
Rarenote not only addresses the "information gap" for cancer and rare disease patients, but also collaborates with patient groups, medical professionals, and pharmaceutical companies to build a data registry, contributing to expanding treatment opportunities for these patients.
● RareNote Related Articles:
RareNote Expands Business to Rare Cancers: https://economist.co.kr/article/view/ecn202502230016
Humanscape Partners with Hana Bank and the Korea Rare and Incurable Disease Association to Build Rare Disease Patient Health Data: http://www.hitnews.co.kr/news/articleView.html?idxno=50922
● Inquiries
Please email help@humanscape.io. The RareNote team welcomes suggestions and feedback from medical professionals, pharmaceutical companies, patient groups, and patients/guardians.
